Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Radioactive Iodide (131I) Treatment of 124I PET/CT Detected Breast Cancers
- Status
- WITHDRAWN
- Phase
- NA
A Clinical Trial of Docetaxel and Oxaliplatin in Patients With Recurrent or Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Radiation and CP-675,206 Infusion for Breast Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Confirmation Study of Eribulin in Combination With Capecitabine
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Enumeration and Molecular Characterization of Circulating Tumour Cells in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Breast Cancer Study: Paclitaxel Versus Paclitaxel Plus Sorafenib in Second- or Third-line Treatment
- Status
- COMPLETED
- Phase
- PHASE2
High Resolution 3D Diffusion-weighted Breast MRI
- Status
- TERMINATED
- Phase
- N/A
A Trial of Standard Chemotherapy With Metformin (vs Placebo) in Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
BEZ235 Trial in Patients With HER2-(Human Epidermal Growth Factor Receptor 2 Negative) /HR+ (Hormonal Receptor Positive) Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Patient-reported Outcome Questionnaire for Women With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE1